High-risk non-ST-elevation acute coronary syndrome as a severe clinical manifestation of Cogan's Syndrome
Main Article Content
Abstract
Article Details
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
The magazine does not retain the reproduction rights (copyright) so the authors can republish their works with the sole mention of the original publication source.
References
Tayer-Shifman, O.E., Ilan, O., Tovi, H. et al. (2014). Cogan's Syndrome—Clinical Guidelines and Novel Therapeutic Approaches. Clinical Reviews in Allergy & Immunology, 47, 65–72. https://doi.org/10.1007/s12016-013-8406-7.
Gluth, M.B., Baratz, K.H., Matteson, E.L., & Driscoll, C.L. (2006). Cogan syndrome: A retrospective review of 60 patients throughout a half century. Mayo Clinic Proceedings, 81(4), 483-488. https://doi.org/10.4065/81.4.483.
Grasland, A., Pouchot, J., Hachulla, E., Blétry, O., Papo, T., & Vinceneux, P. (2004). Typical and atypical Cogan's syndrome: 32 cases and review of the literature. Rheumatology, 43(8), 1007-1015. https://doi.org/10.1093/rheumatology/keh228.
Unizony, S., Stone, J.H., & Stone, J.R. (2013). New treatment strategies in large-vessel vasculitis. Current Opinion in Rheumatology, 25(1), 3-9. https://doi.org/10.1097/BOR.0b013e32835b133a.
Mazlumzadeh, M., & Matteson, E.L. (2007). Cogan's syndrome: An audiovestibular, ocular, and systemic autoimmune disease. Rheumatic Disease Clinics of North America, 33(4), 855-874. https://doi.org/10.1016/j.rdc.2007.07.015.